What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
His primary scientific interests are in Alzheimer's disease, Dementia, Internal medicine, Disease and Pathology.
His primary area of study in Alzheimer's disease is in the field of Clinical Dementia Rating.
While the research belongs to areas of Dementia, John C. Morris spends his time largely on the problem of Cognition, intersecting his research to questions surrounding Clinical psychology.
John C. Morris combines subjects such as Endocrinology and Oncology with his study of Internal medicine.
In his study, which falls under the umbrella issue of Disease, Frontotemporal lobar degeneration is strongly linked to Genetics.
His Cerebrospinal fluid study combines topics in areas such as Central nervous system and Amyloid.
His most cited work include:
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease (9237 citations)
- The Clinical Dementia Rating (CDR): Current version and scoring rules (6434 citations)
- Current concepts in mild cognitive impairment. (3686 citations)
What are the main themes of his work throughout his whole career to date?
John C. Morris mostly deals with Alzheimer's disease, Internal medicine, Disease, Dementia and Pathology.
His Alzheimer's disease research is multidisciplinary, incorporating elements of Cognition, Neuroscience, Cognitive decline, Biomarker and Degenerative disease.
His studies in Internal medicine integrate themes in fields like Gastroenterology, Endocrinology and Oncology.
The concepts of his Disease study are interwoven with issues in Clinical trial and Neuroimaging.
A large part of his Dementia studies is devoted to Clinical Dementia Rating.
John C. Morris mostly deals with Amyloid in his studies of Pathology.
He most often published in these fields:
- Alzheimer's disease (27.72%)
- Internal medicine (26.06%)
- Disease (21.46%)
What were the highlights of his more recent work (between 2017-2021)?
- Alzheimer's disease (27.72%)
- Internal medicine (26.06%)
- Disease (21.46%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Alzheimer's disease, Internal medicine, Disease, Dementia and Oncology.
His study looks at the intersection of Alzheimer's disease and topics like Cognition with Cognitive decline.
His Internal medicine research incorporates elements of Gastroenterology and Endocrinology.
Disease is closely attributed to Positron emission tomography in his work.
His studies deal with areas such as Pittsburgh compound B, Cerebrospinal fluid, Neurodegeneration and Atrophy as well as Biomarker.
As part of his studies on Pathology, he often connects relevant subjects like White matter.
Between 2017 and 2021, his most popular works were:
- Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study (409 citations)
- Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. (337 citations)
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease (238 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
His primary areas of investigation include Internal medicine, Alzheimer's disease, Disease, Dementia and Biomarker.
His biological study spans a wide range of topics, including Gastroenterology and Oncology.
John C. Morris is interested in Presenilin, which is a branch of Alzheimer's disease.
He works mostly in the field of Disease, limiting it down to concerns involving Immunology and, occasionally, Neurology.
In Dementia, John C. Morris works on issues like Asymptomatic, which are connected to Cohort.
The study incorporates disciplines such as Clinical trial, Cerebrospinal fluid, Cross-sectional study, Pittsburgh compound B and Apolipoprotein E in addition to Biomarker.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
